Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the ...

Delcath Systems Inc. (NASDAQ:DCTH) saw its shares rise 2.2% in premarket trading Thursday after new research underscored the potential survival benefits of its liver-targeted treatment for metastatic ...

We focus on a lot of studies investigating metastatic cancer, a disease that occurs when cancer cells spread from their original anatomical location to a distant part of the body. So, let’s take a ...

Liver cancer, primarily hepatocellular carcinoma, originates in the liver, with hepatitis B and C as major risk factors. Diagnosis involves physical exams, blood tests, imaging, and possibly biopsy to ...

MASLD and Liver Cancer: What’s the Link? Metabolic dysfunction-associated steatotic liver disease (MASLD) is a condition where too much fat builds up in your liver. Unlike fatty liver caused by heavy ...

Researchers at Weill Cornell Medicine with an international team have used liver biopsies to identify cellular and molecular markers that can potentially be used to predict whether and when pancreatic ...

-- S.N., Daytona Beach, Fla. A. A short answer to your question is, if alcohol abuse doesn't directly result in the development of liver cancer, it certainly contributes to it. There are two forms of ...